Literature DB >> 11874748

Sleep apnea and intracranial hypertension in men.

Andrew G Lee1, Karl Golnik, Randy Kardon, Michael Wall, Eric Eggenberger, Sunita Yedavally.   

Abstract

PURPOSE: To investigate sleep apnea as an associated finding in idiopathic intracranial hypertension (IIH) in men.
DESIGN: Multicenter, retrospective, noncomparative interventional case series.
METHODS: Retrospective review of all men with the diagnosis of IIH seen within the last 5 years at three tertiary care academic ophthalmologic institutions. Cases with sleep apnea (SA) and IIH were identified and reviewed.
RESULTS: Thirty-two cases of IIH in men were reviewed. Six cases with SA met the modified Dandy criteria for the diagnosis of IIH. Of these six patients, one received acetazolamide alone, four received acetazolamide and continuous positive airway pressure (CPAP), and one was treated with CPAP alone. All patients had preserved central acuity (20/20 or better in both eyes), enlarged blind spots, and optic disc edema in both eyes. Five patients had normal visual fields after treatment, and one patient had residual visual field loss. Three patients had normal optic nerve examinations, with resolution of the optic disc edema at last follow-up. After resolution of the optic disc edema, these three patients were maintained on CPAP but discontinued acetazolamide. Two patients had persistent but improved papilledema and are under continued treatment with acetazolamide and CPAP. One patient had optic disc pallor in both eyes and is stable.
CONCLUSIONS: SA was a common finding in men meeting the modified Dandy criteria for IIH in adults. Treatment of sleep apnea with nocturnal oxygenation may improve the signs and symptoms of IIH in affected men.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874748     DOI: 10.1016/s0161-6420(01)00987-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  34 in total

1.  [Ocular risks in obstructive sleep apnea syndrome].

Authors:  A Steindel; C Lautenschläger; H G Struck
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

Review 2.  Pseudotumor cerebri.

Authors:  Paul W Brazis
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

3.  Racial differences in idiopathic intracranial hypertension.

Authors:  B B Bruce; P Preechawat; N J Newman; M J Lynn; V Biousse
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

Review 4.  Sleep apnea in pediatric neurological conditions.

Authors:  Gabor Szuhay; Josh Rotenberg
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

5.  Chronic optic disc swelling overlooked in a diabetic patient with a devastating outcome.

Authors:  Tasanee Braithwaite; Gordon T Plant
Journal:  BMJ Case Rep       Date:  2010-03-23

6.  Retinal and optic nerve evaluation by optical coherence tomography in adults with obstructive sleep apnea-hypopnea syndrome (OSAHS).

Authors:  Paula Casas; Francisco J Ascaso; Eugenio Vicente; Gloria Tejero-Garcés; María I Adiego; José A Cristóbal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-03       Impact factor: 3.117

7.  Changes of visual field and optic nerve fiber layer in patients with OSAS.

Authors:  Chen Xin; Wei Zhang; Li Wang; Diya Yang; Jun Wang
Journal:  Sleep Breath       Date:  2014-05-08       Impact factor: 2.816

8.  Headaches and papilloedema in a pregnant woman with polycystic ovarian syndrome.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2011-03-01

Review 9.  Epidemiology and risk factors for idiopathic intracranial hypertension.

Authors:  John Chen; Michael Wall
Journal:  Int Ophthalmol Clin       Date:  2014

10.  Risk factors for idiopathic intracranial hypertension in men: a case-control study.

Authors:  J Alexander Fraser; Beau B Bruce; Janet Rucker; Lisa-Ann Fraser; Edward J Atkins; Nancy J Newman; Valérie Biousse
Journal:  J Neurol Sci       Date:  2009-11-30       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.